SCHEMBL20985298

SCHEMBL20985298

[2H]C([2H])([2H])NC(=O)c1nnc(NC(C)=O)cc1Nc1ncccc1SC

nearest known ligand 0.55

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
TYK2 P29597 20/20 0.55
JAK1 P23458 2/20 0.47
JAK2 O60674 1/20 0.47
JAK3 P52333 1/20 0.47
STAT3 P40763 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30940507 0.86 TYK2 (0.52) TYK2JAK1JAK2JAK3
SCHEMBL20985218 0.86 TYK2 (0.52) TYK2JAK1JAK2JAK3
SCHEMBL20985221 0.85 TYK2 (0.53) TYK2JAK1JAK2JAK3STAT3
SCHEMBL20985309 0.85 TYK2 (0.54) TYK2JAK1JAK2JAK3STAT3
SCHEMBL20985261 0.85 TYK2 (0.43) TYK2JAK1JAK2JAK3
SCHEMBL20985232 0.85 TYK2 (0.43) TYK2JAK1JAK2JAK3
SCHEMBL20985248 0.84 TYK2 (0.51) TYK2JAK1JAK2JAK3STAT3
SCHEMBL20985223 0.84 TYK2 (0.51) TYK2JAK1JAK2JAK3STAT3
SCHEMBL20985281 0.83 TYK2 (0.63) TYK2JAK1JAK2JAK3STAT3
SCHEMBL20985242 0.83 TYK2 (0.62) TYK2JAK1JAK2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12365667-B2 Sulfone pyridine alkyl amide-substituted heteroaryl compounds BRISTOL-MYERS SQUIBB COMPANY (US) 2025-07-22 US disclosed
US-20240002364-A1 SULFONE PYRIDINE ALKYL AMIDE-SUBSTITUTED HETEROARYL COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 2024-01-04 US disclosed
US-11787779-B2 Sulfone pyridine alkyl amide-substituted heteroaryl compounds BRISTOL-MYERS SQUIBB COMPANY (US) 2023-10-17 US disclosed
US-20210253554-A1 SULFONE PYRIDINE ALKYL AMIDE-SUBSTITUTED HETEROARYL COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY 2021-08-19 US disclosed
US-11021462-B2 Sulfone pyridine alkyl amide-substituted heteroaryl compounds BRISTOL-MYERS SQUIBB COMPANY (US) 2021-06-01 US disclosed
EP-3713930-A1 SULFONE PYRIDINE ALKYL AMIDE-SUBSTITUTED HETEROARYL COMPOUNDS Bristol-Myers Squibb Company (US) 2020-09-30 EP disclosed
CN-111315737-A Sulfonylpyridinylalkylamide substituted heteroaryl compounds 百时美施贵宝公司 2020-06-19 CN disclosed
WO-2019103952-A1 SULFONE PYRIDINE ALKYL AMIDE-SUBSTITUTED HETEROARYL COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 2019-05-31 WO disclosed
US-20190152948-A1 SULFONE PYRIDINE ALKYL AMIDE-SUBSTITUTED HETEROARYL COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY 2019-05-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11021462-B2 Sulfone pyridine alkyl amide-substituted heteroaryl compounds TYK2, JAK3, JAK2 TYK2 1/4885JAK1 4/4885JAK2 3/4885
US-20210253554-A1 SULFONE PYRIDINE ALKYL AMIDE-SUBSTITUTED HETEROARYL COMPOUNDS TYK2, JAK3, JAK2 TYK2 1/4885JAK1 4/4885JAK2 3/4885
US-11787779-B2 Sulfone pyridine alkyl amide-substituted heteroaryl compounds TYK2, JAK3, JAK2 TYK2 1/4885JAK1 4/4885JAK2 3/4885
US-20240002364-A1 SULFONE PYRIDINE ALKYL AMIDE-SUBSTITUTED HETEROARYL COMPOUNDS TYK2, JAK3, JAK2 TYK2 1/4885JAK1 4/4885JAK2 3/4885
US-12365667-B2 Sulfone pyridine alkyl amide-substituted heteroaryl compounds TYK2, JAK3, JAK2 TYK2 1/4885JAK1 4/4885JAK2 3/4885
US-20190152948-A1 SULFONE PYRIDINE ALKYL AMIDE-SUBSTITUTED HETEROARYL COMPOUNDS TYK2, JAK3, JAK2 TYK2 1/4885JAK1 4/4885JAK2 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.